The commission earlier Thursday issued a recall alert for the migraine medication, urging consumers to secure the product out of sight and reach of children and to contact Pfizer for a free child-resistant pouch to store the product. Pfizer said customers don't need to return the drug.
"Patients should be rest assured that there are no quality or safety issues nor health risks when they take the medicine as prescribed for its approved use," Pfizer said.
No incidents or injuries tied to the product have been reported, the commission said.